MA31692B1 - Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine - Google Patents

Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine

Info

Publication number
MA31692B1
MA31692B1 MA32671A MA32671A MA31692B1 MA 31692 B1 MA31692 B1 MA 31692B1 MA 32671 A MA32671 A MA 32671A MA 32671 A MA32671 A MA 32671A MA 31692 B1 MA31692 B1 MA 31692B1
Authority
MA
Morocco
Prior art keywords
benzoferanil
polymorphisms
amino methyl
carbonyl amino
carbonyl
Prior art date
Application number
MA32671A
Other languages
Arabic (ar)
English (en)
Inventor
Leanda Jane Kindon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA31692B1 publication Critical patent/MA31692B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes cristallines de (s)-2-((4-benzofuranyl)carbonylam
MA32671A 2007-09-13 2010-03-05 Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine MA31692B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0717882.5A GB0717882D0 (en) 2007-09-13 2007-09-13 Novel pharmaceutical
PCT/EP2008/062064 WO2009034133A1 (fr) 2007-09-13 2008-09-11 Formes polymorphes de (s)-2-((4-benzofuranyl)carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine

Publications (1)

Publication Number Publication Date
MA31692B1 true MA31692B1 (fr) 2010-09-01

Family

ID=38658914

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32671A MA31692B1 (fr) 2007-09-13 2010-03-05 Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine

Country Status (22)

Country Link
US (1) US20100286201A1 (fr)
EP (1) EP2190842A1 (fr)
JP (1) JP2010539133A (fr)
KR (1) KR20100057035A (fr)
CN (1) CN101801968A (fr)
AR (1) AR068414A1 (fr)
AU (1) AU2008297126A1 (fr)
BR (1) BRPI0816757A2 (fr)
CA (1) CA2699472A1 (fr)
CL (1) CL2008002688A1 (fr)
CO (1) CO6260068A2 (fr)
CR (1) CR11306A (fr)
DO (1) DOP2010000066A (fr)
EA (1) EA201070361A1 (fr)
GB (1) GB0717882D0 (fr)
MA (1) MA31692B1 (fr)
MX (1) MX2010002895A (fr)
PE (1) PE20090639A1 (fr)
TW (1) TW200927748A (fr)
UY (1) UY31337A1 (fr)
WO (1) WO2009034133A1 (fr)
ZA (1) ZA201001083B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101110A1 (en) * 2010-10-26 2012-04-26 Sangamesh Badiger Diaza-spiro[5.5]undecanes
US20190151304A1 (en) 2016-05-10 2019-05-23 Inserm (Institut National De La Santé Et De La Rechercjae Médicale Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677354B2 (en) * 2000-06-16 2004-01-13 Smithkline Beecham P.L.C. Piperdines for use as orexin receptor antagonists
WO2006081522A2 (fr) * 2005-01-26 2006-08-03 The Regents Of The Unversity Of California Modulation de courants du recepteur nmda au moyen du recepteur de l'orexine et/ou du recepteur du facteur crf

Also Published As

Publication number Publication date
GB0717882D0 (en) 2007-10-24
EA201070361A1 (ru) 2010-08-30
AR068414A1 (es) 2009-11-18
TW200927748A (en) 2009-07-01
MX2010002895A (es) 2010-04-01
CN101801968A (zh) 2010-08-11
CO6260068A2 (es) 2011-03-22
CR11306A (es) 2010-04-20
AU2008297126A1 (en) 2009-03-19
ZA201001083B (en) 2010-10-27
US20100286201A1 (en) 2010-11-11
KR20100057035A (ko) 2010-05-28
CL2008002688A1 (es) 2009-11-27
DOP2010000066A (es) 2010-04-15
EP2190842A1 (fr) 2010-06-02
CA2699472A1 (fr) 2009-03-19
WO2009034133A1 (fr) 2009-03-19
PE20090639A1 (es) 2009-06-25
UY31337A1 (es) 2009-04-30
BRPI0816757A2 (pt) 2015-03-17
JP2010539133A (ja) 2010-12-16

Similar Documents

Publication Publication Date Title
EP1954683A4 (fr) 2-(phenyl ou heterocyclique)-1h-phenantrho(9,10-d)imidazoles utilisees comme inhibiteurs de la mpges-1
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
SMT201300098B (it) Forme solide di N-(4-(7-azabiciclo[2.2.1]eptan-7-il)-2-(trifluorometil)fenil-4-osso-5-trifluorometil)-1,4-diidrochinolina-3-carbossammide
ATE452635T1 (de) Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
CR20120421A (es) Compuestos de aminohetetoarilo o sustituidos con pirazol como inhibidores de proteina quinasa
ATE384039T1 (de) Indanderivate als muscarinrezeptoragonisten
MX345541B (es) Formas solidas de (r)-1(2,2-difluorobenzo[d] [1,3]dioxol-5-il)-n-( 1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il) -1h-indol-5-il) ciclopropanocarboxamida.
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
BRPI0822929A2 (pt) Composições compreendendo derivados de álcool benzílico e também compostos ativos antimicrobianos
DK1919907T3 (da) Heterocyklisk forbindelse
ATE510832T1 (de) Heterocyclische verbindungen als c-fms- kinasehemmer
DE602006015297D1 (de) 3-azetidincarbonsäure-derivate zur verwendung als immunsuppressiva
EP2276469A4 (fr) Agonistes des récepteurs alpha-adrénergiques destinés au traitement de la discopathie dégénérative
EP1874736A4 (fr) Composes heterocycliques fusionnes
CA2705357C (fr) Formulations pour proteines hybrides taci-immunoglobuline
CY1112829T1 (el) Νεα μεθοδος συνθεσης για την αγομελατινη
MA32788B1 (fr) 1-(arylsulfonyl)-4-(piperazine-1-yl)-1h-benzimidazoles servant de ligands de la 5-hydroxytryptamine-6
ITBO20050696A1 (it) Macchina per la produzione di filtri composti
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
EP2183247A4 (fr) Nouvelles formes cristallines de citrate de 2-hydroxy-3-ý5-(morpholin-4- ylméthyl)pyridin-2-yl¨1<i>h</i>-indole-5-carbonitrile
ATE512953T1 (de) Heterocyclische verbindungen
ZA200803226B (en) Heterocyclic Compounds as Pstat3/IL-6 Inhibitors
MA31259B1 (fr) Formes solides d'un inhibiteur des kinases raf
ATE526324T1 (de) Substituierte imidazolverbindungen als ksp- inhibitoren